MEMPHIS, Tenn., Tuesday, June 22, 2010—Duncan-Williams, Inc. (DWI) announced an addition to its expanding Equity Capital Markets Division.
Irina Rivkind joins Duncan-Williams, Inc.’s New York office as a Senior Vice President. Ms. Rivkind’s is an analyst in the Equity Capital Markets Division and will specialize in small-to-mid cap specialty pharmaceutical companies.
Ms. Rivkind has spent over three years as an Equity Associate Analyst
covering the pharmaceutical and generics sector at UBS. Prior to that
she has ten years of pharmaceutical industry experience, which includes
management roles in both research and marketing at Forest Laboratories
as well as a progression of clinical trial management positions in
contract research organizations, including Quintiles. Ms. Rivkind
graduated from Cornell University, with a B.A. in Biological Sciences,
and also holds an M.S. in Epidemiology from the University of Maryland
and an MBA from the NYU School of Business.
Ms. Rivkind will work as an analyst in Equity Capital Markets under the direction of James Terwilliger, an Executive Managing Director. “We are excited about Irina joining Duncan-Williams, and we look forward to her building out a research platform in the specialty pharmaceutical arena,” says Terwilliger.
In 2008, Duncan-Williams, Inc. launched its 500 @ 50 initiative, a comprehensive growth plan coordinated with the firm’s 50th anniversary in 2019 to transform DWI into a leading financial services company with approximately $500 million in annual revenue.
About Duncan-Williams, Inc.
Duncan-Williams, Inc., is a Top 100 Brokerage Firm headquartered in Memphis, Tenn. The firm is a full-service brokerage and investment banking firm providing financial solutions to retail and institutional organizations in 50 states and 11 foreign countries. Duncan-Williams, Inc., is a member of FINRA and SIPC. Duncan-Williams, Inc., has offices in New York, Jersey City, NJ, Chicago, Houston, Charlotte, Jackson, MS, Hattiesburg, MS, Nashville, and Knoxville, TN. Additional information is available at www.duncanwilliams.com